跳至主要内容
临床试验/NCT02820506
NCT02820506进行中(未招募)不适用

Sentinel Node Mapping With Robotic Assisted Near Infra-red Fluorescent Imaging in Women With Cervical and Endometrial Cancer

University of Southern Denmark8 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2017年2月27日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
300
试验地点
8
主要终点
Sensitivity

研究概览

简要总结

The aim of the study is to evaluate the feasibility of applying the SLN mapping technique in combination with FDG-PET/CT imaging in women with high-risk histology endometrial cancer and in patients with cervical cancer tumour size 2-4 cm.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Study IIA: Patients with cervical cancer, FIGO IB1, tumor size 2-4 cm
  • Study IIB: Patients with high risk endometrial cancer, presumed FIGO I, type 1 histology grade 3 Endometrioid adenocarcinoma or type 2 histology (serous-, clearcel-, carcinosarcoma or undifferentiated adenocarcinoma.

排除标准

  • Known allergy towards ICG and/or iodine (ICG contains 5% sodium iodine)
  • Women included in other studies affecting outcome-measures of the present study

结局指标

主要结局

Sensitivity

时间窗: 2 years

Sensitivity of sentinel lymph node mapping compared to the sensitivity of sentinel lymph node mapping combined with removal of PET-positive lymph nodes

Negative predictive value

时间窗: 2 years

Negative predictive value of sentinel lymph node mapping algorithm, and a sentinel lymph node mapping algorithm including removal of PET-positive lymph nodes

次要结局

  • Positive predictive value(2 years)
  • Quality of life rate(3 years)
  • Specificity(2 years)
  • Incidence of lymphedema(3 years)
  • Severity of lymphedema(3 years)
  • Prevalence of lymph node metastasis(2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sara Sponholtz

MD

University of Southern Denmark

研究点 (8)

Loading locations...

相似试验